← FDA Drug Approvals (Drugs@FDA)
EMBLAVEO
NDA · New Drug Application · Sponsor: ABBVIE · Approved 2025-02-07
Drug application
- FDA Application #
NDA217906- Application type
- New Drug Application
- Brand name
- EMBLAVEO
- Generic name
- AZTREONAM AND AVIBACTAM
- Active ingredients
- AVIBACTAM SODIUM; AZTREONAM
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- ABBVIE
- Manufacturer
- AbbVie Inc.
- First approval
- 2025-02-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown